Clinical Trial Update: 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine [Phase 4]

View source ↗

Summary

This Phase 4 trial compared 24-hour plasma glucose profiles between insulin lispro mix 75/25 and insulin glargine in adults with type 2 diabetes and has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog Mix75/25 (Insulin lispro)
• Lantus (insulin glargine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED